Bain Capital
Search documents
X @Bloomberg
Bloomberg· 2025-12-04 16:34
Private market firm Bain Capital and Japan’s Sumitomo Mitsui Banking Corp. are joining forces for a new European loan platform targeting corporate borrowers in Europe and UK https://t.co/AXBZpMCPOz ...
These 3 charts show how the biggest private equity funds keep winning in a fundraising slowdown
Yahoo Finance· 2025-12-04 13:01
Core Insights - The private equity industry is experiencing significant consolidation, with a notable increase in capital flowing to the largest funds [1][2][8] Fundraising Trends - In 2025, nearly 46% of all private equity capital raised has been secured by the 10 largest funds, up from 34.5% in 2024, with predictions indicating that over 40% will go to the largest funds in 2026 [2] - Total fundraising has decreased substantially, with only $259 billion raised so far this year compared to $372.6 billion last year, marking an 8% year-over-year drop in the absolute amount raised by the top funds to $118.3 billion [3][5] Share of Top Funds - The top 10 funds are capturing a larger share of the fundraising haul than in the past decade, with their share rising to 45.7% this year from an average of 35.8% over the last five years [4][5] - The three largest funds raised $60.4 billion this year, accounting for 23.3% of the total amount raised, compared to $55.9 billion last year, which was only 15% of the total [7] Notable Funds - The top 10 funds include Thoma Bravo Fund XVI ($24.3 billion), Blackstone Capital Partners IX ($21 billion), and Veritas Capital Fund IX ($14.4 billion), among others [6]
Asia-Pacific markets set to track Wall Street gains on rising Fed rate-cut expectations
CNBC· 2025-11-25 23:39
Market Overview - Asia-Pacific markets opened higher, influenced by Wall Street gains and expectations of a potential U.S. Federal Reserve interest rate cut in December [1][3] - Markets are pricing in over an 84% chance of a Fed rate cut in December, with New York Fed President indicating room for lower rates "in the near term" [3] Company Performance - Kioxia's shares fell more than 12% following reports that Bain Capital plans to sell approximately 350 billion yen ($2.24 billion) worth of shares, reducing its ownership from 51% to 44% [4] - Kioxia reported fiscal second-quarter earnings that missed expectations, leading to a 23.03% drop in its shares the following day [5] Regional Market Movements - Japanese tech stocks saw gains, with Advantest rising 2.5% and Tokyo Electron increasing by 0.61% [3] - South Korea's Kospi advanced by 0.67%, while the small-cap Kosdaq climbed 0.64% [5] - Australia's ASX/S&P 200 was trading 1.2% higher, with inflation accelerating in October, marking the fastest pace in seven months [5][6]
X @Bloomberg
Bloomberg· 2025-11-25 09:20
A Bain Capital-backed entity will dump a stake in Kioxia Holdings in a block trade as the stock has surged since its initial public offering about a year ago https://t.co/5hgpRpR9UV ...
Portfolio Adjustment: Institutional Heavyweight Exits Biotech Stock
Yahoo Finance· 2025-11-19 15:24
Core Insights - Bain Capital has sold its entire stake in Disc Medicine, indicating a shift in sentiment towards the biotech company [4][5][6] - Disc Medicine focuses on developing innovative therapies for rare hematologic diseases, leveraging scientific expertise in red blood cell biology [3][5] - Despite Bain's exit, Disc Medicine's stock has continued to perform well, reaching a 52-week high [5][6] Company Overview - Disc Medicine is a biotechnology firm that targets rare and severe blood disorders, primarily serving healthcare providers and hospitals [1][3] - The company operates on a research-driven model, investing in the discovery and clinical development of novel treatments [2][3] Financial Performance - As of November 14, 2025, Disc Medicine shares were priced at $89.95, reflecting a 48.3% increase over the past year, outperforming the S&P 500 by 30.13 percentage points [4][5] - The complete sale by Bain Capital resulted in a net reduction of $30,902,160, with the position previously accounting for approximately 3.9% of the fund's assets under management [5][6] Market Implications - The exit of a significant institutional player like Bain Capital may signal potential skepticism regarding future growth prospects for Disc Medicine [6][7] - Retail investors should be aware of this development, as it could indicate broader market sentiment towards the company [7]
X @Bloomberg
Bloomberg· 2025-11-17 15:44
Buyout firm Bain Capital is acquiring private golf club operator Concert Golf Partners from Clearlake Capital https://t.co/0xCup0Mjj7 ...
Omnicom Executive to Lead Brand Consulting Firm That Works With Private Equity
WSJ· 2025-11-17 11:00
Group 1 - Fundamentalco, which focuses on brand strategy, was spun out from Blackstone in 2024 [1] - The company serves notable clients including Bain Capital, Visa, and Hilton [1]
Bain Capital's Connaughton on Private Markets
Yahoo Finance· 2025-11-17 08:27
Core Viewpoint - Bain Capital is focusing on long-duration investments in private companies aimed at generating compound returns over a five to seven year investment horizon rather than engaging in quick asset flips [1] Group 1 - Bain Capital's strategy emphasizes long-duration holdings in private companies [1] - The firm is targeting a five to seven year investment horizon [1] - John Connaughton, Managing Partner at Bain Capital, discussed these strategies exclusively on Bloomberg's Insight [1]
X @Bloomberg
Bloomberg· 2025-11-06 10:26
Bain Capital has picked banks for an IPO of Eleda, a Swedish infrastructure projects and services provider https://t.co/rRW9Ys7MNp ...
Perpetual enters exclusive talks with Bain Capital over wealth unit divestment
Yahoo Finance· 2025-11-05 08:50
Core Viewpoint - Australia's Perpetual is in exclusive discussions with Bain Capital Private Equity regarding the potential sale of its Wealth Management arm, although there is no guarantee of a binding agreement or transaction proceeding [1]. Group 1: Sale Discussions - Perpetual has signed an exclusivity deed with Bain Capital as it moves forward with discussions about selling its Wealth Management division [1]. - Earlier in 2024, Perpetual had a A$2.18 billion ($1.42 billion) agreement with KKR to sell both its wealth management and corporate trust operations, but later decided to sell only the wealth management segment separately [2]. - The company has previously attracted takeover interest, rejecting a A$1.7 billion offer from a consortium including Regal Partners in 2022 and a A$3.1 billion bid from its largest shareholder, Washington H Soul Pattinson, in 2023 [3][4]. Group 2: Financial Performance - For the recent full-year results, Perpetual's Wealth Management division reported revenue of A$235.6 million, reflecting a 4% increase from the previous year [2]. - Despite the revenue increase, underlying profit before tax decreased by 5%, attributed to slower growth in non-market-related income and higher costs [3]. - The Wealth Management division manages A$21.5 billion in funds under advice [3]. Group 3: Operational Overview - Perpetual operates globally across asset management, wealth management, and trustee services under various brands, including Perpetual, Barrow Hanley, Pendal, J O Hambro, Regnan, TSW, and Trillium [4]. - Wealth management services are provided through Perpetual Private, Fordham, and Jacaranda Financial Planning, while the corporate trust division serves managed funds and the debt market both locally and internationally [5]. - Perpetual has a global presence with offices in Asia, Europe, the US, and the UK [5].